Amphotericin B: CAS No: 1397-89-3 Amphotericin B is an API used to treat a number of fungal infections. This pharmaceutical ingredient is aggressive when interacting with the fungus which is why it’s generally used for serious cases only. However, it’s also proven itself to be one of the most effective ways to stop the spread[…]
Amphotericin B: A Serious and Effective Treatment for Extreme Fungal Infections
Anti-Fungal, Drug Research & Development API Tags: Amphotericin B Jul 25, 2018
Anidulafungin: An Effective Echinocandin Against Aggressive Fungal Infections
Anti-Fungal Tags: Amphotericin BAnidulafungin May 10, 2018
Anidulafungin CAS No: 166663-25-8 Anidulafungin is an antifungal API used to combat general yeast infections found in the blood, stomach, or esophagus and some varieties of Aspergillus. As an echinocandin, it inhibits the growth of fungal cell walls which results in either fungal cell instability or death. Echinocandins are unique in that they affect the[…]
Spotlight on Posaconazole: A Leading Antifungal Medication
Anti-Fungal Tags: Amphotericin BAntifungalfungusPosaconazole Mar 20, 2018
Posaconazole CAS No:171228-49-2 Posaconazole is a type of oral triazole antifungal API that has shown a high rate of efficacy for a number of fungal conditions without the risk of severe side effects. While many antifungal medications have ostensibly similar jobs, each one has their own limitations and patient disadvantages. Posaconazole was developed as an[…]
Fungal Infections Face a Force to be Reckoned With-Amphotericin B
Anti-Fungal, Bulk Active Ingredient, Drug Research & Development API, Patent Expiration 2016 Tags: Amphotericin BHIV Aug 14, 2012
Amphotericin B is also known as the brand name Ambisone. With Astellas Pharma’s patent for Ambisome due to expire on February 23, 2016, this injectable medication for deadly fungal infections is geared up for attention in the pharmaceutical community. More than 6 billion dollars is spent worldwide on anti-fungal medications, and the total costs of[…]
Is Voriconazole the New Primary Treatment for Orbital Aspergillosis?
Anti-Fungal, Drug Research & Development API Tags: Amphotericin BPfizer Mar 26, 2012
Voriconazole is also known as the brand name Vfend, which is marketed by Pfizer. As an antifungal medication, voriconazole is typically reserved for treating patients with serious fungal infections, like invasive aspergillosis. Voriconazole is a formidable opponent for fungal infections that begin in the lungs and spread through the bloodstream to other organs, like invasive[…]
